An innovative new interventional clinical trial is launching in the St. Paul’s Hospital (SPH) emergency department this week (June 11).
The Rapid Agitation Control with Ketamine in the Emergency Department (RACKED) Study will compare the effectiveness of intramuscular ketamine to a standard combination of intramuscular medications in patients presenting to the emergency department (ED) with agitation and violent behaviour.
ED physician David Barbic will lead the study, which is funded by the St. Paul’s Emergency Department Research Fund, the Canadian Association of Emergency Physicians, and PHCRI. CHÉOS Scientists Drs. Brian Grunau and Hubert Wong are co-investigators on the team. CHÉOS will also provide of project management, regulatory affairs, data management, programming, and statistical support.
